No credit card. No commitment.
5000+ G2 reviews
Tezcat Biosciences
Research
Founded in 2018
New Haven, Connecticut
tezcat.coTezcat Biosciences
ResearchFounded in 2018New Haven, Connecticut
EmployeesTezcat Biosciences' financial review
Employees
4
Tezcat Biosciences information
Tezcat Biosciences is committed to the research and development of novel biologic-based therapies to treat the most aggressive cancers. The first-generation technology has been optimized for tumor-specific killing, solid tumor penetration, and manufacturability. Born out of NYU Langone Health, our team is committed to refining and delivering the leading-edge technology from bench to bedside. Tezc...
Tezcat Biosciences is committed to the research and development of novel biologic-based therapies to treat the most aggressive cancers. The first-generation technology has been optimized for tumor-specific killing, solid tumor penetration, and manufacturability. Born out of NYU Langone Health, our team is committed to refining and delivering the leading-edge technology from bench to bedside. Tezcat Biosciences has participated in the 2018 Entrepreneurship Lab (ELab) Program, an initiative of NYC's Economic Development Corporation (NYCEDC), and the Texas Medical Center's Accelerator for Cancer Therapeutics (TMC-ACT).
Tezcat Biosciences industries
Research
Biotechnology research
Tezcat Biosciences' financial review
Employees
4
Employee Metrics
Technologies
Email Providers
Other
Analytics and Tracking
Load Balancers
Other
CMS
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
